Log in to save to my catalogue

Activation of Naïve B Lymphocytes via CD81, a Pathogenetic Mechanism for Hepatitis C Virus-Associate...

Activation of Naïve B Lymphocytes via CD81, a Pathogenetic Mechanism for Hepatitis C Virus-Associate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16339892

Activation of Naïve B Lymphocytes via CD81, a Pathogenetic Mechanism for Hepatitis C Virus-Associated B Lymphocyte Disorders

About this item

Full title

Activation of Naïve B Lymphocytes via CD81, a Pathogenetic Mechanism for Hepatitis C Virus-Associated B Lymphocyte Disorders

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2005-12, Vol.102 (51), p.18544-18549

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Infection with hepatitis C virus (HCV), a leading cause of chronic liver diseases, can associate with B lymphocyte proliferative disorders, such as mixed cryoglobulinemia and non-Hodgkin lymphoma. The major envelope protein of HCV (HCV-E2) binds, with high affinity CD81, a tetraspanin expressed on several cell types. Here, we show that engagement o...

Alternative Titles

Full title

Activation of Naïve B Lymphocytes via CD81, a Pathogenetic Mechanism for Hepatitis C Virus-Associated B Lymphocyte Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_16339892

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_16339892

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0509402102

How to access this item